Policy Statement

Policy Statement 2017-03-02T16:34:51+00:00

Guidelines for the Avoidance of Inadvertent Anticompetitive Conduct

Policy

The American Osteopathic Colleges of Ophthalmology and Otolaryngology-Head and Neck Surgery, with the advice of the AOA’s legal counsel, has adopted guidelines that must be followed to avoid inadvertent anticompetitive conduct that could be attributed to the AOCOO-HNS. These guidelines shall apply to all of the AOCOO-HNS fellows, members, board members, officers, councilors, committee members, representatives to other professional or governmental organizations, and employees.

Background

The Supreme Court of the United States has held that a trade association would be liable under the federal antitrust laws for treble damages arising from unlawful acts of one of its representatives, even if those acts were not authorized by the organization, if the representative had the “apparent authority” (viewed from the perspective of outsiders) to speak or act in the name of and with the apparent endorsement or backing of the organization. The Court held that the appearance of authority could be created, for example, if the representative’s unlawful acts were statements written on the organization’s letterhead or other writing or oral statements made in the representative’s capacity with the organization. The Court’s holding applies to all membership organizations, including the AOCOO-HNS.

Evaluation

It is essential that all personnel and representatives of the AOCOO-HNS be specifically aware of the types of conduct that might be found to constitute anticompetitive conduct and that they adhere to straightforward guidelines designed to avoid inadvertent anticompetitive conduct and the possible attribution of that conduct to the AOCOO-HNS.

Guidelines

Except when expressly authorized in advance either by the Board of Governors of the AOCOO-HNS or in a manner determined by the Board of Governors:

  1. The following subjects should not be discussed at any formal or informal meeting of the fellows and members, the Board of Governors, the Colleges Boards, or by any AOCOO-HNS representative to any formal or informal meeting of any other professional or governmental organization, and must be avoided in all other contacts with actual or potential competitors:
    • (a) Discussions about, or that may have the effect of, fixing, raising, depressing, pegging or stabilizing prices or fees, or any element of prices or fees, or establishing minimum or maximum prices or fees;
    • (b) Discussions about, or that may have the effect of, either withholding patronage or services from, or otherwise discouraging dealings with, or encouraging exclusive dealings with, any health care provider or group of health care providers, any supplier or purchaser or group of suppliers or purchasers, of health care products or services, any actual or potential competitor or group of actual or potential competitors, or any patient, group of patients, or other segment of the public;
    • (c) Discussions about, or that may have the effect of, allocating or dividing geographic or service markets, customers or patients;
    • (d) Discussions about, or that may have the effect of, restricting, limiting, prohibiting or sanctioning advertising, or soliciting which is not false, misleading or deceptive;
    • (e) Discussions about, or that may have the effect of, discouraging entry into or competition in any segment of the health care market;
    • (f) Discussions about whether or not the practices of any member, actual or potential competitor, or other person are “unethical” or “anticompetitive”; and
    • (g) Discussions about the safety, quality or efficacy of the products or services of, or the prices or fees changed by, any health care provider or group of health care providers, any supplier or purchaser or group of suppliers or purchasers of health care products or services, or any actual or potential competitor or group of actual or potential competitors. This does not restrict or prohibit study and reasonable discussion and assessment of the safety or efficacy of technology, drugs and devices.
  2. Minutes shall be prepared and maintained for all meetings of the fellows and members, the Board of Governors, the Colleges Boards and committees of the AOCOO-HNS. Except for matters protected by the attorney-client privilege, all discussions conducted and all decisions reached at those meetings shall be reflected in the minutes of those meetings. AOCOO-HNS representatives to other organizations shall take responsible steps to ensure that minutes of the meetings of those organizations are prepared and maintained, except for matters protected by the attorney-client privilege, and that all discussions conducted and decisions reached at those meetings are reflected in the minutes of those meetings.
  3. No fellow, member, board member, officer, committee member, representative or employee of the AOCOO-HNS shall have the authority to, or shall, issue any written statement on AOCOO-HNS letterhead to anyone or any of the subjects enumerated in item 1 above.
  4. No fellow, member, board member, officer, committee member, representative or employee of the AOCOO-HNS shall have the authority to, or shall, issue any oral or other written statement to anyone on any of the subjects enumerated in item 1 above, in which or in connection with which, the person issuing the statement identifies his or her affiliation with the AOCOO-HNS or purports to act on behalf of, in the name of, or with the endorsement of or backing of the AOCOO-HNS.
  5. Notwithstanding anything apparently or expressly to the contrary contained in the proceeding items, a person who is affiliated with the AOCOO-HNS and who has been specifically authorized by the AOCOO-HNS or its Board of Governors or its Executive Committee to communicate in the name of and on behalf of the AOCOO-HNS to representatives of the executive and legislative branches of government with respect to administrative or legislative proposals which are under consideration by those branches and are of direct concern to the AOCOO-HNS, shall not be required to comply with item 3 or item 4 above with respect to any oral or written communication which
    • (a) Is first approved by the Board of Governors or in a manner determined by the Board of Governors; and
    • (b) Related solely to the substance or merits of a proposal which is then the subject of administrative or legislative hearings or proceedings being conducted by the executive or legislative branch or government and which does or could, if adopted, relate to the science and art of medicine pertaining to the eye and/or ear, nose and throat and related structures or to the provision of or in payment or services involving prevention, diagnosis, or treatment of disorders affecting the eye and/or ear, nose and throat and related structures; and
    • (c) Is made by that person as a participant in these meetings or proceedings and solely in connection with that participation; and
    • (d) Is made directly and solely to a representative of the executive or legislative branch of government who is a participant in those hearings or proceedings with copies of such communications provided only to persons designated by the Board of Governors of the AOCOO-HNS or in a manner determined by the Board of Governors.
  6. An exact copy of each written statement described in items 3, 4 or 5 above and an exact transcription of each oral statement described in items 4 or 5 above, whether or not the statement has been expressly authorized in advance either by the Board of Governors or the AOCOO-HNS or in a manner determined by the Board of Governors, shall be furnished to the AOCOO-HNS’s Executive Vice President immediately after the statement is issued, together with a complete record of its distribution.

Approved by: Board of Governors, May 1997